Fig. 6
From: Renal function in β-thalassemia major patients treated with two different iron-chelation regimes
Comparison of serum Cr, eGFR and urine Ca/Cr in the patients reported in the previous study to the same patients [20] treated with DFO in our previous study and with DFX in the current study, Serum Cr (p < 0.0001), eGFR (p = 0.0093), urinary Ca/Cr (p = 0.001) (Wilcoxon matched-pair t test). (DFX) Deferasirox. (DFO) Desferrioxamine. (DFP) Deferiprone